Navigation Links
Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke

r mini-stroke but no known coronary heart disease. In these patients, Lipitor significantly reduced the risk of coronary heart disease events by 43 percent compared with those taking placebo. The risk of stroke was reduced by 12 percent and major coronary events by 26 percent, but these results were not statistically significant.

"This analysis reminds us of the importance of managing patients' overall risk factors to reduce the risk of serious complications," said Dr. Welch.

About the SPARCL Study

The SPARCL study, published in the New England Journal of Medicine in 2006, is the only study to date evaluating statin therapy exclusively for patients with recent stroke or mini-stroke and no coronary heart disease (n=4,731). Lipitor 80 mg is the only statin to have shown stroke benefit in these patients. Lipitor 80 mg reduced the risk of an additional stroke by 16 percent and major coronary events by 35 percent compared with placebo. In a post-hoc analysis of the SPARCL trial, there was a higher incidence of hemorrhagic stroke in patients taking Lipitor 80 mg compared with patients taking placebo. Patients with prior hemorrhagic stroke at study entry appeared to be at an increased risk of hemorrhagic stroke.

In SPARCL, Lipitor was well tolerated. The rate of side effects such as elevated liver enzymes was low and consistent with the known safety profile and there was no difference in the incidence of muscle weakness or rhabdomyolysis between groups. Lipitor 80 mg is not a starting dose.

About Lipitor

Lipitor is extensively studied and the most prescribed cholesterol-lowering therapy in the world, with nearly 139 million patient-years of experience. Lipitor is supported by an extensive clinical trial program involving more than 400 ongoing and completed trials with more than 80,000 patients.

Important Safety Information

Lipitor is a prescription medication. It is used in patients with multiple risk factors for hear
'"/>




Page: 1 2 3

Related medicine technology :

1. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
2. Lipitor Provides Unprecedented Cardiovascular Risk Reductions in Diabetes Patients with Metabolic Syndrome and in Stroke Patients
3. Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
4. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
5. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
6. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
7. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
8. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
9. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
10. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
11. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
Post Your Comments:
(Date:3/4/2015)... , March 4, 2015  Mail-service and specialty ... consumers, employers and government health plans $11.8 billion ... by the Pharmaceutical Care Management Association (PCMA). ... offers one of the easiest ways to reduce ... Mark Merritt . "Policymakers should resist efforts to ...
(Date:3/4/2015)... UPM Pharmaceuticals, a division of Gregory Pharmaceutical ... to manufacture Flibanserin 100 mg tablets. Sprout has submitted ... drug approved to treat hypoactive sexual desire disorder (HSDD), ... The tablets will be manufactured at UPM,s 475,000 ... . Dr. John M. Gregory , ...
(Date:3/4/2015)... 2015   Aratana Therapeutics, Inc . (NASDAQ: ... the licensing, development and commercialization of innovative biopharmaceutical products ... at the Barclays Global Healthcare Conference to ... Beach Hotel in Miami , FL.  ... President and Chief Executive Officer of Aratana Therapeutics, will ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 3Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2
... 25, 2007 /PRNewswire-FirstCall/ --,Phosphagenics Limited (AIM: PSG) announced ... dermal drug delivery,technology formulated with retinoic acid, a ... ingredient used in,anti-aging cosmetics. , The proof of ... of retinoic acid delivered into the skin when ...
... Pfizer announced today,that Lipitor (atorvastatin calcium) Tablets 80 ... events and major coronary events,in type 2 diabetes ... who had experienced a recent stroke or mini-stroke, ... analysis of the landmark,Stroke Prevention by Aggressive Reduction ...
Cached Medicine Technology:Phosphagenics Announces Positive Proof of Concept Results from,Studies Utilizing Company's Dermal Drug Delivery Technology 2Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 2Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 3
(Date:3/4/2015)... March 04, 2015 With the growing influence ... lives of our teens and young adults, combined with the ... and confusing to try to keep up with what kids ... or trend is replaced on a daily basis. , The ... and the slang that is used to discreetly talk about ...
(Date:3/4/2015)... BC (PRWEB) March 04, 2015 Starting ... perform LASIK and PRK procedures at their new location ... Correction, Dr. Joseph King and Dr. Gabriel Chu also ... practice in Surrey is named Fraser Valley Cataract and ... is accredited by the College of Physicians and Surgeons ...
(Date:3/4/2015)... New York, NY (PRWEB) March 04, 2015 ... within the centerfold of The San Francisco Chronicle with ... readership of 500,000 readers. Its digital component is distributed ... a network of top news sites and partner outlets. ... click here. , Milorganite is composed of ...
(Date:3/4/2015)... 04, 2015 As seen on ... can be a painful condition in which the ... of the uterus leading to very unpleasant symptoms and ... can have a terrible effect on women’s quality of ... the most common cause of infertility in women and ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The popular ... of their new L-Style Revolution™ Program. The customized program ... and women of all health and fitness levels to ... goals faster than traditional methods. , “We’re really proud ... customized plans based on award winning techniques to help ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:King LASIK relocates to Surrey, British Columbia 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:The Makers of Liporidex, The Popular Sports Nutrition Supplement Brand, Launches Its New L-Style Revolution™ Diet & Exercise Program That Promises Turbo Charged Results 2
... gum disease , , WEDNESDAY, Dec. 12 (HealthDay News) ... and a weakened immune response may be to blame, ... In experiments with mice infected with the bacteria ... battle gum infection than their normal-weight counterparts, according to ...
... 12 CG Technology has changed its,name to ... depth,and breadth of services it offers. Carlisle & ... standards of work, while focusing its,business on the ... Consulting Group (CG) is a management consulting,and project-based ...
... System Detects Illegal Payments and Providers, AUSTIN, ... and an NBC News report, U.S. taxpayers are ... to unqualified doctors and health,care providers. A new ... however, can make a significant impact on reducing ...
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer ... today announced that James L. Cox, M.D. has,agreed ... Cox, reputation as a,preeminent authority in the surgical ... serves as the foundation for ATS 3f(R),tissue valve ...
... We are encouraged by the,positive results of the ... D.C., showing promising strides in the right direction,with significant ... of a larger trend for all measured age groups ... past six years (2001-2007)., MTF, now in its ...
... presents $5,000 each to six community organizations in ... underserved areas, ... it will provide a total of $30,000 in end of,year donations to ... given to six agencies in northern and,southern California to assist vulnerable populations., ...
Cached Medicine News:Health News:Obesity Weakens Immune Response 2Health News:Technology can Dramatically Reduce Billions of Dollars in Medicaid, Medicare Fraud 2Health News:ATS Medical Appoints James L. Cox, M.D. as Medical Director 2Health News:ATS Medical Appoints James L. Cox, M.D. as Medical Director 3Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study 2Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study 3Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study 4Health News:Blue Cross of California Gives $30,000 in Holiday Donations to Food Banks Throughout the State 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: